# Oral Dosage Form New Animal Drugs; Change of Sponsor; Griseofulvin Powder; Levamisole Hydrochloride Powder; Oxytetracycline Powder
> **Food and Drug Administration** · Final rule. · Published 2012-05-14 · Effective 2012-05-14 · 77 FR 28252
## Document
- **Document number:** 2012-11382
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 28252
- **CFR reference:** 21 CFR 520
- **Publication date:** 2012-05-14
- **Effective date:** 2012-05-14
- **HHS docket:** Docket No. FDA-2012-N-0002
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for five abbreviated new animal drug applications (ANADAs) for griseofulvin powder, levamisole hydrochloride soluble powder, and oxytetracycline hydrochloride soluble powder from Teva Animal Health, Inc., to Cross Vetpharm Group, Ltd.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/05/14/2012-11382/oral-dosage-form-new-animal-drugs-change-of-sponsor-griseofulvin-powder-levamisole-hydrochloride)
---
*AI Analytics · CC0 1.0*